EMA Application withdrawn: Alendronic Acid / Colecalciferol Mylan (alendronate sodium trihydrate;colecalciferol) — Mylan S.A.S.

View source ↗

Summary

The EMA withdrew the application for Alendronic Acid / Colecalciferol Mylan (alendronate sodium trihydrate; colecalciferol) for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Alendronic Acid / Colecalciferol Mylan (alendronate sodium trihydrate; colecalciferol)

Snippet

Status: Application withdrawn. Therapeutic area: Osteoporosis. MAH: Mylan S.A.S.. Decision date: 24/06/2016